Trial Profile
Exenatide and Cardiac Energetics in Type 2 Diabetes: A pilot Study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Jun 2016
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 28 Apr 2015 Accrual to date is 74% according to United Kingdom Clinical Research Network record.
- 17 Jan 2013 Status changed from recruiting to active, no longer recruiting according to United Kingdom Clinical Research Network record.
- 01 Sep 2012 Accrual to date is 72% according to United Kingdom Clinical Research Network record.